Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Contraception ; 75(5): 372-7, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17434019

RESUMO

BACKGROUND: Levonorgestrel (LNG) 1.5 mg administered within 72 h of unprotected coitus is an established method of emergency contraception. Currently, there is some, although incomplete, knowledge about the mechanism of action. METHODS: We administered 1.5 mg LNG peri-ovulatory to determine the effects on serum gonadotrophins, estradiol and progesterone levels. Fourteen women were studied in a pretreatment and treatment cycle; eight women (Group A) took LNG 3 days before the expected day of ovulation, while 6 (Group B) took LNG a day before the expected day of ovulation. RESULTS: The women in Group A had a significant delay in their LH peak and onset of the next menses compared with their pretreatment cycles (26.4 vs. 39.1 days, p<.05). Those in Group B had no significant changes in the endocrine parameters but there was a significant shortening of the mean cycle length in comparison with their pretreatment cycles (25.1 vs. 20.2 days). CONCLUSION: Levonorgestrel 1.5 mg acts as an emergency contraception by delaying the LH surge and interfering with ovulation. It may also disrupt corpus luteum formation causing premature luteinization of unruptured follicles.


Assuntos
Anticoncepcionais Femininos/farmacologia , Corpo Lúteo/efeitos dos fármacos , Levanogestrel/farmacologia , Hormônio Luteinizante/efeitos dos fármacos , Ciclo Menstrual/efeitos dos fármacos , Adulto , Anticoncepção Pós-Coito , Anticoncepcionais Femininos/administração & dosagem , Feminino , Humanos , Levanogestrel/administração & dosagem , Hipófise/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...